| Note |
When schizophrenia puts them out of reach. Withdrawn schizophrenic patients, who only see mirror images of their own depression and apathy endlessly repeated, may be difficult to reach. By effectively controlling first rank symptoms, Fluanxol allows you to begin to deal with the negative symptomatology of the withdrawn schizophrenic. The mood elevating properties of Fluanxol can increase alertness, co-operation and a desire for social contact. All with little or no daytime sedation and a low incidence of anticholinergic and cardiovascular effects. In addition, two dosage formats, depot and tablets, help improve compliance. Fluanxol. It can put them within reach. |
